Thalidomide inhibits the replication of human immunodeficiency virus type 1.

Thalidomide, a selective inhibitor of tumor necrosis factor alpha (TNF-alpha) synthesis, suppresses the activation of latent human immunodeficiency virus type 1 (HIV-1) in a monocytoid (U1) line. The inhibition is dose dependent and occurs after exposure of the cells to recombinant TNF-alpha, phorbo...

Descrición completa

Detalles Bibliográficos

Publicado en:	Proc Natl Acad Sci U S A
Principais autores:	Makonkawkeyoon, S, Limson-Pobre, R N, Moreira, A L, Schauf, V, Kaplan, G
Formato:	Artigo
Idioma:	Inglês
Publicado:	National Academy of Sciences 1993
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC46849/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8327469/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.90.13.5974
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!